Chongqing Pharmaceutical Research Institute

Chongqing Pharmaceutical Research Institute (CQPHRI) is a leading Chinese pharmaceutical research and manufacturing entity established in 1950. Now a key subsidiary of Fosun Pharma, the institute focuses on the R&D of innovative drugs and high-end generic pharmaceuticals. Its core competencies include chemical synthesis, process development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. CQPHRI maintains a strong international presence with multiple products certified by the US FDA and European authorities. The organization serves as a critical hub for Fosun Pharma's chemical drug segment, driving advancements in metabolic, cardiovascular, and anti-tumor therapies.